Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Multiple System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing therapeutics with...
Company to host conference call and webcast on Monday, August 15, 2022, at 8:00am ETBOSTON and ATLANTA, Aug. 12, 2022 /PRNewswire/ -- Inhibikase T...
Harold passed away Friday, April 29, 2022, from complications of Multiple System Atrophy.
/PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying...